3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Neoplasms
6
Leukemia
3
Leukemia, Myeloid, Acute
2
Disease
2
Colorectal Neoplasms
2
Uveal Melanoma
1
Uterine Cervical Dysplasia
1
Sexually Transmitted Diseases
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Oropharyngeal Neoplasms
1
Myelodysplastic Syndromes
1
Motor Activity
1
Lymphoma
1
Lung Neoplasms
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Infertility
1
Hypergammaglobulinemia
1
Hospitalism
1
Hematological Cancer
1
Hematologic Diseases
1
Hemangiosarcoma
1
Head and Neck Neoplasms
1
Gestational Trophoblastic Tumours
1
Genetic Predisposition to Disease
1
Gastrointestinal Stromal Tumors
1
Exanthema
1
Dermatitis, Seborrheic
1
Depression
1
Interventions
Dexamethasone
3
isatuximab
2
Lenalidomide
2
Cyclophosphamide
2
pomalidomide
1
fludarabine phosphate
1
fludarabine
1
daratumumab
1
Watchful Waiting
1
Vorinostat
1
Vincristine
1
Specimen Handling
1
Rituximab
1
Ranitidine
1
R-CHOP protocol
1
Prednisone
1
Interviews as Topic
1
Injections
1
Histone Deacetylase Inhibitors
1
Filgrastim
1
Exercise
1
Doxorubicin
1
Diphenhydramine
1
Data Collection
1
Bortezomib
1
Acetaminophen
1
AC protocol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Hematologic Diseases
×
Interviews as Topic
×
Clear all
NCT03272789
2019-01-23
REBOND
Institut Paoli-Calmettes
Phase NA
Unknown
32 enrolled